Mulmit

Eledon Pharmaceuticals, Inc.Eledon Pharmaceuticals, Inc.

ELDN Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2016-12-310-5,128,000-5,655,000
2015-12-310-45,261,000-45,087,000

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2035-01-10Robinson James A. Jr.30,870
2026-07-31Gros David-Alexandre CChief Executive Officer354,454
2026-07-31Gros David-Alexandre CChief Executive Officer194,791
2026-07-31Perrin StevenPresident152,353
2026-07-31Perrin StevenPresident72,138
2026-01-10McBride John S.3,430
2026-01-10McBride John S.3,430
2026-01-10Hillson Jan3,430
2026-01-10Hillson Jan3,430
2026-01-10Kirk Allan3,430
2026-01-10Kirk Allan3,430
2026-01-10Katkin Keith8,575

8-K events

FiledItems
2026-08-13Results of operations · Financial statements and exhibits
2026-06-22Amendments to charter or bylaws · Submission of matters to a vote · Financial statements and exhibits
2026-05-13Results of operations · Financial statements and exhibits
2026-03-19Results of operations · Financial statements and exhibits
2026-01-02Unregistered sales of equity securities · Financial statements and exhibits
2025-11-14Results of operations · Financial statements and exhibits
2025-11-13Entry into a material agreement · Financial statements and exhibits
2025-11-07Results of operations · Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…